Sharemaestro Newsreel

Quantinno Capital Management LP Buys Shares of 174,095 Schrodinger, Inc. $SDGR

Quantinno Capital Management LP has acquired 174,095 shares of Schrodinger, Inc. (NASDAQ:SDGR) for approximately $1.98 million during the first quarter. This investment is part of a trend where several institutional investors have increased their holdings in Schrodinger, with institutions now owning 79.05% of the …

Renaissance Technologies LLC Has $2.02 Million Position in Certara, Inc. $CERT

Renaissance Technologies LLC significantly increased its stake in Certara, Inc. (NASDAQ:CERT) by 1,097.6% in the first quarter, now holding 354,500 shares valued at $2.02 million. Other institutional investors have also adjusted their positions in Certara, with a total of 73.96% of the company's stock …

Assenagon Asset Management S.A. Invests $6.87 Million in Hinge Health Inc. $HNGE

Bank of America Corp DE Has $49.79 Million Stake in Waystar Holding Corp. $WAY

Bank of America Corp DE significantly increased its stake in Waystar Holding Corp. (NASDAQ:WAY) by 61.8% in the first quarter, now holding 2.07 million shares valued at nearly $49.8 million. This move comes as Waystar reported strong Q1 earnings, with EPS exceeding estimates and …

Schrödinger (SDGR) Is Up 19.2% After AI Pact With BMS And Q2 Profitability - Has The Bull Case Changed?

Schrödinger (SDGR) saw its stock rise by 19.2% following the announcement of its Q2 2026 profitability and an expanded AI partnership with Bristol Myers Squibb. The agreement integrates Schrödinger's "Bunsen" AI co-scientist into Bristol Myers Squibb's research, bolstering the company's investment thesis that its …

3 Stocks Under $10 with Questionable Fundamentals

3 Stocks Under $10 with Questionable Fundamentals Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn't mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals. The …

(OMCL) Price Dynamics and Execution-Aware Positioning

Omnicell Inc. (NASDAQ: OMCL) is exhibiting choppy conditions due to divergent sentiment across all time horizons, with support currently being tested. The AI models have generated three distinct trading strategies: a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Strategy, each …

3 Mid-Cap Stocks with Solid Fundamentals

3 Mid-Cap Stocks with Solid Fundamentals In today's market, large companies dominate the landscape and grow their leads by acquiring smaller competitors - a trend that will accelerate with the Trump administration. However, some mid-sized players will continue thriving because they've carved durable niches …

Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of "Hold" from Analysts

Health Catalyst, Inc. (NASDAQ:HCAT) has received a consensus "Hold" rating from thirteen analysts, with an average 12-month price target of $2.95. The company recently reported better-than-expected quarterly EPS of $0.04 and revenue of $70.49 million, though it remains unprofitable with a negative net margin. …

1 Cash-Producing Stock with Promising Prospects and 2 We Ignore

1 Cash-Producing Stock with Promising Prospects and 2 We Ignore Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Not all companies are …

Certara, Inc. (CERT) Stock Forecasts

The article provides a stock forecast for Certara, Inc. (CERT), a company focused on accelerating medicines using biosimulation software. It highlights an Argus research report from August 5, 2026, which includes a current price of $8.13 and a price target for CERT. The content …

Technical Reactions to HQY Trends in Macro Strategies

This article provides a technical analysis of Healthequity Inc. (NYSE: HQY), highlighting strong near and mid-term sentiment, potential for long-term extension, and compelling upside due to no resistance above the current price. It outlines three AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk …

Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $1,000,800.00 in Stock

Schrödinger Unveils Bunsen, an AI Co-Scientist for Enhanced Molecular Discovery

Schrödinger, Inc. has launched Bunsen, an AI co-scientist designed to assist researchers in molecular discovery by leveraging AI and physics-based simulations. This tool aims to streamline scientific workflows, allowing for more hypotheses to be evaluated and accelerating discovery decisions. Bunsen operates on a computing …

MiniMed Poised to Roll Out New Innovations in Diabetes Devices but Has Yet to Dig a Moat

MiniMed, recently spun out from Medtronic, is focusing on innovation in diabetes device technology. The company, a leader in durable, tubed insulin pumps for Type 1 diabetes, faces increasing competition despite its historical market presence. An analyst note initiates coverage with a "no-moat" rating …

Tempus AI CEO, data Ryan Fukushima sells $1,000,800 in shares

Tempus AI's CEO of Data, Ryan Fukushima, sold 20,000 shares of the company's Class A Common Stock for over $1 million on August 7, 2026, at an average price of $50.04 per share. This sale was conducted under a Rule 10b5-1 trading plan. The …

Sean Duffy Sells 12,942 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health CEO Sean Duffy recently sold 12,942 shares of the company's stock for approximately $321,091, reducing his ownership by 3.05%. This transaction comes as Omada Health exceeded quarterly earnings and revenue estimates. The company maintains a "Moderate Buy" consensus rating from analysts with …

Tempus AI (TEM) executive’s spouse sells 20,000 shares under 10b5-1 plan

Tempus AI (TEM) CEO, Data, Fukushima Ryan's spouse sold 20,000 shares of Class A Common Stock on August 7, 2026, for a weighted average price of $50.04 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on March 12, 2026. …

Insider Selling: Omada Health (NASDAQ:OMDA) CEO Sells 8,628 Shares

Omada Health CEO Sean Duffy sold 8,628 shares of the company's stock for $188,521.80, reducing his direct ownership by 2.05%. This sale occurred despite Omada Health reporting better-than-expected quarterly earnings and revenue, though the stock saw a 3.9% decline. Analysts generally maintain a "Moderate …

Talkspace: Payor Revenue Jumps 27% As Health Plan Customers Grow 26% Ahead Of UHS Acquisition

Talkspace's Q2 2026 revenue increased 13.6% to $61.7 million, largely driven by its Payor business, which saw a 27.1% increase in revenue to $51.5 million and a 25.8% rise in health plan customers. This growth comes as the company deliberately reduces its direct consumer …

Health Catalyst (NASDAQ:HCAT) Price Target Cut to $2.00 by Analysts at Citigroup

Citigroup has reduced its price target for Health Catalyst (NASDAQ:HCAT) from $2.50 to $2.00, while maintaining a "neutral" rating, indicating a potential 12% upside from its previous close. Despite beating quarterly EPS and revenue estimates, the company continues to report substantial losses, and analysts …

HCAT Maintained by Citigroup -- Price Target Lowered to $2.00

Citigroup has maintained a neutral rating for Health Catalyst (HCAT) but lowered its price target from $2.50 to $2.00. Despite the stock being potentially undervalued by 58.8% according to GuruFocus's GF Value, concerns remain about the company's profitability and valuation. Investors are advised to …

Company (NASDAQ: WAY) insider Matthew Hawkins details option exercise and stock sales

Waystar Holding Corp. insider Matthew J. Hawkins has filed to sell 22,462 common shares, valued at $554,811.40, which are expected to be issued from a stock option exercise on August 11, 2026. The filing also reveals previous 10b5-1 plan sales and one non-10b5-1 sale …

OMDA (OMDA) Form 144 details stock option exercise and planned share sale

Omada Health, Inc. (OMDA) filed a Form 144 indicating a planned sale of 2,715 common shares, stemming from a stock option exercise on August 11, 2026. The filing also details previous 10b5-1 sales by Steven Cook over the past three months, totaling significant share …

How Investors Are Reacting To Certara (CERT) Expanding Buybacks Amid Wider Losses And Leadership Changes

Certara (CERT) recently reported Q2 2026 results with higher sales but significantly wider net losses. In response, the company expanded its share repurchase authorization to $150 million and announced leadership changes. This has led to questions about Certara's balance between growth investments, leadership focus, …

Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup

It's a great feeling when a stock you own absolutely skyrockets higher after reporting earnings. Two software-as-a-service (SaaS) stocks, Atlassian (NASDAQ: TEAM) and Doximity (NYSE: DOCS), gave their investors something to cheer about when both companies' share prices skyrocketed more than 30% this past …

DarioHealth Corp. Q2 2026 Earnings Call Summary

DarioHealth Corp. Q2 2026 Earnings Call Summary - Moby Strategic Evolution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Health, Inc. HIMS reported quarterly adjusted loss per share of 10 cents in second-quarter 2026, against the year-ago period's adjusted earnings per share (EPS) of 17 cents. The metric was wider than the Zacks Consensus Estimate of loss per share of …

Tempus Q2 Earnings Call Highlights Data Growth and Pricing Upside

GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook

Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q2 CY2026 results beating Wall Street's revenue expectations , but sales fell by 1.3% year on year to $200.4 million. The company's full-year revenue guidance of $797.5 million at the midpoint came in 2.8% above analysts' estimates. Its …

Waystar Holding (WAY) Is Up 9.0% After Raising 2026 Outlook And Naming New CFO

Waystar Holding (WAY) saw its stock rise 9.0% after reporting strong Q2 2026 results, increasing its full-year 2026 revenue guidance to US$1.276 billion–US$1.294 billion, and completing a US$12.68 million share buyback. The company also announced Alpana Wegner as its new CFO, a move expected …

DarioHealth Q2 Earnings Call Highlights

Key Points Interested in DarioHealth Corp.? Here are five stocks we like better. Q2 revenue fell to $5.2 million as DarioHealth continued moving away from pharmaceutical services toward recurring B2B2C revenue, but gross margin improved to 62% and net loss narrowed to $7.9 million. …

Earnings call transcript: DarioHealth tops q2 2026 EPS forecast, misses revenue

DarioHealth (DRIO) reported a narrower-than-expected loss in Q2 2026, beating EPS forecasts by 32% with adjusted earnings of negative $0.85 per share, but missed revenue estimates at $5.18 million. The company's stock rose 4.93% after the announcement, driven by improved gross margins (62%) and …

Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls

Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 …

Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

Key Points Interested in Omada Health, Inc.? Here are five stocks we like better. Omada Health reported record second-quarter results, with revenue rising 43% year over year to $88 million, gross margin reaching 74% and adjusted EBITDA totaling $10.8 million. The company is broadening …

Hims & Hers Health Earnings: What To Look For From HIMS

Hims & Hers Health Earnings: What To Look For From HIMS Telehealth company Hims & Hers Health (NYSE:HIMS) will be announcing earnings results this Monday after market hours. Here's what to expect. Hims & Hers Health missed analysts' revenue expectations last quarter, reporting revenues …